Topic: genomics sequencing
Two discoveries related to a combination treatment and genetic testing could improve the prognosis for patients with pancreatic cancer.
Despite recent advances, the world still knows very little about biology, and drug development is still mostly about trial and error due to that lack of understanding. 10x Genomics is building tools that help pierce the veil of complex biology and disease to unlock new possibilities in biomedical research.
10x Genomics raked in an additional $35 million through an extension of its series D round, which brought in $50 million last April.
Vancouver-based Contextual Genomics has launched two molecular hotspot assays for detecting genomic mutations in blood and solid tumors.
An expanded understanding of the genetics behind breast cancer and blood pressure could improve treatments.
Machine learning identified mutations in 60 genes that raise the risk of abdominal aortic aneurysm (AAA).
Loxo is preparing for a November verdict from the FDA on larotrectinib as a treatment for solid tumors with NTRK fusions.
Merck paired up with Foundation Medicine to develop a pan-cancer diagnostic for Keytruda to measure microsatellite instability and other biomarkers.
Charles River partners with PathoQuest to offer clients NGS solutions for biologics viral contamination testing and cell-line genetic characterization.
The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.